If you’re aiming to ramp up your protein intake (welcome to the club), protein bars and shakes might come to mind first—these products are indeed turbocharged with the muscle-building macro. But you ...

The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.

It’s hard to believe it’s only been about nine months since the trade that rocked Dallas to its core. We’re not even a season removed from an NBA transaction that led to huge protests and a public ...